当前位置: X-MOL 学术ACS Chem. Biol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Targeting of G-Quadruplex Harboring Pre-miRNA 92b by LNA Rescues PTEN Expression in NSCL Cancer Cells
ACS Chemical Biology ( IF 3.5 ) Pub Date : 2018-03-12 00:00:00 , DOI: 10.1021/acschembio.7b00749
Gayan Mirihana Arachchilage 1 , Prakash Kharel 1 , Joshua Reid 1 , Soumitra Basu 1
Affiliation  

Since the elevated levels of microRNAs (miRNAs) often cause various diseases, selective inhibition of miRNA maturation is an important therapeutic strategy. Commonly used anti-miRNA strategies are limited to targeting of mature miRNAs, as the upstream targeting of miRNA maturation with an oligonucleotide is challenging due to the presence of a stable pre-miRNA stem-loop structure. Previously, we reported that about 16% of known human pre-miRNAs have the potential to adopt G-quadruplex (GQ) structures alternatively to canonical stem-loops. Herein, we showed that a rationally designed locked nucleic acid (LNA) binds specifically the GQ conformation of pre-miRNA 92b and inhibits pre-miRNA maturation. Further, we showed that the LNA treatment rescues PTEN expression in non-small-cell lung cancer (NSCLC) cells, which is suppressed by the elevated level of miRNA 92b. Treatment of LNA significantly decreases the IC50 of doxorubicin for NSCLC cells. This strategy can be developed as a novel anti-miRNA therapeutic approach to target GQ harboring miRNAs. This can potentially be a more powerful approach than targeting of the mature miRNA, as it is an upstream targeting and can reduce both 3′ and the 5′ mature miRNA levels at once.

中文翻译:

LNA靶向G-四链体含Pre-miRNA 92b挽救PTEN在NSCL癌细胞中的表达

由于microRNA(miRNA)水平升高通常会导致各种疾病,因此选择性抑制miRNA成熟是一种重要的治疗策略。常用的抗miRNA策略仅限于靶向成熟miRNA,因为由于存在稳定的pre-miRNA茎环结构,用寡核苷酸进行miRNA成熟的上游靶向具有挑战性。先前,我们报道了大约16%的已知人类pre-miRNA具有替代经典茎环采用G-四链体(GQ)结构的潜力。在这里,我们表明,合理设计的锁定核酸(LNA)可以特异性结合pre-miRNA 92b的GQ构象,并抑制pre-miRNA的成熟。此外,我们发现LNA治疗可挽救非小细胞肺癌(NSCLC)细胞中的PTEN表达,这被miRNA 92b的水平升高所抑制。LNA的治疗可显着降低IC50的阿霉素用于NSCLC细胞。可以将这种策略开发为靶向miGs的目标GQ的新型抗miRNA治疗方法。与靶向成熟miRNA相比,这可能是一种更强大的方法,因为它是上游靶向,可以同时降低3'和5'成熟miRNA的水平。
更新日期:2018-03-12
down
wechat
bug